# A Trial to Evaluate the Potential Benefit of Adjuvant Chemotherapy for Small Bowel Adenocarcinoma

> **NCT04257461** · PHASE3 · UNKNOWN · sponsor: **Belgian Group of Digestive Oncology** · enrollment: 30 (estimated)

## Conditions studied

- Small Bowel Adenocarcinoma

## Interventions

- **DRUG:** Fluoropyrimidine
- **DRUG:** Oxaliplatin

## Key facts

- **NCT ID:** NCT04257461
- **Lead sponsor:** Belgian Group of Digestive Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-02-20
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-02-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04257461

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04257461, "A Trial to Evaluate the Potential Benefit of Adjuvant Chemotherapy for Small Bowel Adenocarcinoma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04257461. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*